rapid-acting

• “Lovenox, known generically as enoxaparin, is a rapid-acting version of heparin, the widely used blood thinner critical to millions of heart patients.”

  The Wall Street Journal: New Generic Lovenox Receives FDA Approval

• “The rapid-acting heparin, which carries the generic name enoxaparin, serves an expanding market of consumers with heart disease and obesity-related diabetes.”

  The Wall Street Journal: Sanofi Seeks to Halt Lovenox Generic

• “Lovenox, a rapid-acting blood thinner, brought roughly $4 billion in sales to Sanofi in 2009.”

  The Wall Street Journal: Sanofi Seeks to Halt Lovenox Generic

• “The drug, also known by the generic name enoxaparin, is a rapid-acting form of heparin, a widely used blood thinner.”

  The Wall Street Journal: FDA Approves Generic Lovenox

• “Momenta Pharmaceuticals Inc. sued Teva Pharmaceutical Industries Ltd., the world ' s largest generic-drug maker by sales, over patents related to the blockbuster rapid-acting heparin called enoxaparin.”

  The Wall Street Journal: Momenta Sues Teva Over Patents For Heparin

• “Follow-up interviews and discussions reveal that this method of self-deliverance may be less traumatizing for family members than more rapid-acting methods, such as the ingestion of drugs.”

  Simon & Schuster: imperfect endings

• “I don't see much improvement in overall glucose control in many patients with the rapid-acting insulin taken at meals.”

  The Huffington Post: Diabetes Treatment: How Much Insulin Do You Need?

• “Since Momenta and Sandoz won FDA approval for their rapid-acting heparin in July, the drug ' s sales have topped $300 million.”

  The Wall Street Journal: Watchdog Says FDA Risked Integrity

• “Your hand-held miniaturized rapid-acting virus detector is ready.”

  "Bones" McCoy, call your office:

• “Use of rapid-acting inhaled insulin will not replace the need to inject the hormone occasionally, the Food and Drug Administration said.”

  Various and Sundry: Blu Rays, Tech, HDTV, and More » 2006 » January

Show 10 more examples...